In this study, immunohistochemistry demonstrated that AKR1C1 was highly expressed in metastatic lesions of human bladder cancer patients (Fig. 6a–c and Supplementary Fig. 7c). This evidence concerns the gene AKR1C1 and urinary bladder carcinoma.